Gyrase inhibitors modify metabolising processes in the liver
Staib, A.H.; Harder, S.; Papenburg, A.; Stille, W.
Deutsche Medizinische Wochenschrift 112(44): 1720-1721
1987
ISSN/ISBN: 0012-0472 PMID: 2822371 Document Number: 304409
Document emailed within 1 workday
Related Documents
Petzinger, E. 1991: Gyrase inhibitors, a new class of therapeutic drugs Tierarztliche Praxis 19(1): 14-20Hofstetter, A. 1991: Current chemotherapy in urogenital infections. 4: Gyrase inhibitors Fortschritte der Medizin 109(36): 739
Narang, A.P. 1987: Effect of protein-calorie malnutrition on drug metabolising enzymes in rat liver Indian Journal of Physiology and Pharmacology 31(3): 170-177
Tres, A.; Muñóz, J.R. 1977: Protease inhibitors, alpha-1-antitrypsin and alpha-2-macroglobulin, in liver processes Revista Clinica Espanola 145(6): 407-409
Leber, H.W.; Uviss, T.; Prenter, A. 1979: Influence of the plasticiser di-2-ethylhexyl-phthalate on drug metabolising enzymes in the liver of uraemic rats Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association 16: 232-237
Prasad, M.R. 1977: Developmental patterns of phospholipid metabolising enzymes in the liver and small intestine of the chick embryo Indian Journal of Biochemistry and Biophysics 14(4): 310-315
Llanes, C.; Michel-Briand, Y.; Thouverez, M.; Bailly, C.; Grimont, F. 1990: Stability of conjugative and non-conjugative R-plasmids from Serratia marcescens to gyrase inhibitors Microbiologica 13(2): 157-159
Tempel, K.; Ignatius, A. 1992: Effect of gyrase inhibitors on some eukaryotic short-term test systems. DNase i in vitro nucleic acid synthesis and DNA repair in primary cultures of chicken embryo and rat cells Arzneimittel-Forschung 42(8): 1031-1036
Boehm, H.J.; Boehringer, M.; Bur, D.; Gmuender, H.; Huber, W.; Klaus, W.; Kostrewa, D.; Kuehne, H.; Luebbers, T.; Meunier-Keller, N.; Mueller, F. 2000: Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening Journal of Medicinal Chemistry 43(14): 2664-2674
Eber, B.; Klein, W.; Fluch, N.; Dusleag, J.; Weinrauch, V.; Rotman, B.; Gasser, R.; Kronberger-Schaffer, E. 1989: Do thrombocyte aggregation inhibitors modify silent episodes of unstable angina pectoris in combined anti-angina therapy? Zeitschrift für Kardiologie 78(Suppl 2): 150-154; Discussion 159
Marra, C.A.; de Alaniz, M.J. 1990: Mineralocorticoids modify rat liver delta 6 desaturase activity and other parameters of lipid metabolism Biochemistry International 22(3): 483-493
Cecha, J.ós.; Drabek, G.; Błazelonis, A.; Romanowski, W.; Zubelewicz-Szkodzińska, B. 2004: The role of HMG-CoA reductase inhibitors in regulation of the inflammatory processes Wiadomosci Lekarskie 57(5-6): 255-258
Kavtiashvili, K.G.; Gabuniia, U.A.; Khundadze, T.O.; Dugladze, D.I.; Chumburidze, R.A.; Khananashvili, S.D. 1990: The stimulation of regenerative processes in the liver in acute liver failure Arkhiv Patologii 52(2): 47-52
Vinnikov, A.I.; Kozlova, N.S.; Babenko, I.S.; Zueva, V.S. 1986: Action of inhibitors of the energy processes on the efficiency of staphylococcal phage infection Molekuliarnaia Genetika Mikrobiologiia i Virusologiia 9: 33-35
Ton, S.H.; Karunairatnam, M.C. 1976: Activities of some carbohydrate metabolising enzymes in both the yeast-like and mycelial-like forms of Candida albicans Southeast Asian Journal of Tropical Medicine and Public Health 7(3): 359-362
Slobodin, V.B.; Kuznetsova, V.A. 1982: Characteristics of lipogenesis processes in the liver in experimental burns Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 3: 43-46
Zhabo, V.D. 1978: Effect of inhalatory anesthetics on metabolic processes in the liver Klinicheskaia Khirurgiia 9: 89-90
Grover, S.K.; Srivastava, K.K.; Singh, V.S.; Misra, U.K. 1985: Effect of vitamin A on hepatic microsomal drug metabolising enzymes activity in rats exposed to acute hypoxia International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift für Vitamin- und Ernahrungsforschung. Journal International de Vitaminologie et de Nutrition 55(4): 391-393
Verho, M.; Dagrosa, E.E.; Usinger, P.; Grötsch, H.; Malerczyk, V.; Uchida, M.; Rangoonwala, R. 1985: Renal tolerance of ofloxacin, a new gyrase inhibitor Pharmatherapeutica 4(5): 306-313
Nakanishi, A.; Imajoh-Ohmi, S. 1999: DNA gyrase inhibitor (GyrI) of Escherichia coli Seikagaku. Journal of Japanese Biochemical Society 71(6): 442-448